Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2  (01-2013)

Period of time： 2013年2期

Publisher： Bentham Science Publishers

Founded in： 2003

Total resources： 41

E-ISSN： 1875-6182|11|2

ISSN： 1871-5257

Subject： R5 Internal Medicine

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2

Menu

Editorial (Hot Topic: Pharmacotherapy During Percutaneous Coronary Intervention in Acute Myocardial Infarction)

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-06 , pp. 83-83

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Intracoronary Injection of Drugs to Treat No - Reflow Phenomenon and Microcirculatory Dysfunction

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-06 , pp. 84-88

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Intracoronary Injection of Glycoprotein IIb/IIIa, Abciximab, as Adjuvant Therapy in Primary Coronary Intervention

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-01 , pp. 89-95

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Low - Molecular Weight Heparins and Unfractionated Heparins during Primary Coronary Intervention

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-06 , pp. 96-100

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

P2Y12 Inhibitors: Pharmacologic Mechanism and Clinical Relevance

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-06 , pp. 101-105

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Pharmacological Adjuvant Therapies in Primary Coronary Interventions: Bivalirudin

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-06 , pp. 106-114

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Rosuvastatin and Diabetes: When the Evidences Talk

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-06 , pp. 115-124

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Hypoxia-inducible Factor (HIF) in Hormone Signaling During Health and Disease

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-06 , pp. 125-135

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Combined Antiplatelet Therapy: Still a Sweeping Combination in Cardiology

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents),volume 11,issue 2 , Vol. 11, Iss. 2, 2013-06 , pp. 136-167

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 9 item(s)